| Primary |
| Drug Use For Unknown Indication |
60.0% |
| Hypertension |
20.0% |
| Cardiac Failure |
13.3% |
| Atrial Fibrillation |
6.7% |
|
| Renal Failure |
40.0% |
| Hypotension |
20.0% |
| Renal Failure Acute |
20.0% |
| Suicidal Ideation |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.7% |
| Product Used For Unknown Indication |
14.7% |
| Hypertension |
12.9% |
| Cardiac Failure |
7.9% |
| Atrial Fibrillation |
3.9% |
| Ill-defined Disorder |
3.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Prophylaxis |
2.4% |
| Myocardial Infarction |
2.1% |
| Congestive Cardiomyopathy |
1.7% |
| Thrombosis Prophylaxis |
1.5% |
| Diabetes Mellitus |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Endocarditis |
1.3% |
| Hypothyroidism |
1.3% |
| Ischaemic Cardiomyopathy |
1.2% |
| Depression |
1.0% |
| Essential Hypertension |
1.0% |
| Lung Infection |
1.0% |
|
| Renal Failure Acute |
16.0% |
| Renal Failure |
12.5% |
| Thrombocytopenia |
9.0% |
| Toxic Skin Eruption |
6.5% |
| Interstitial Lung Disease |
6.0% |
| Vomiting |
6.0% |
| Orthostatic Hypotension |
5.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.0% |
| Hypotension |
4.0% |
| Respiratory Failure |
4.0% |
| Eczema |
3.5% |
| Tricuspid Valve Incompetence |
3.5% |
| Sinus Bradycardia |
3.0% |
| Hepatic Neoplasm Malignant |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Rash |
2.5% |
| Urinary Retention |
2.5% |
| Ventricular Fibrillation |
2.5% |
| Weight Decreased |
2.5% |
| Coombs Positive Haemolytic Anaemia |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.7% |
| Product Used For Unknown Indication |
22.5% |
| Hypertension |
9.9% |
| Atrial Fibrillation |
7.6% |
| Cardiac Failure |
3.7% |
| Prophylaxis |
2.9% |
| Hiv Infection |
2.5% |
| Myocardial Infarction |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Renal Transplant |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Depression |
1.9% |
| Thrombosis Prophylaxis |
1.8% |
| Unevaluable Event |
1.8% |
| Pain |
1.7% |
| Arrhythmia |
1.6% |
| Osteoporosis |
1.5% |
| Diabetes Mellitus |
1.5% |
| Multiple Myeloma |
1.5% |
| Anxiety |
1.4% |
|
| Renal Failure Acute |
20.3% |
| Renal Failure |
9.3% |
| Thrombocytopenia |
7.8% |
| Vomiting |
7.6% |
| Weight Decreased |
6.5% |
| International Normalised Ratio Increased |
6.3% |
| Rhabdomyolysis |
5.2% |
| Somnolence |
4.1% |
| Toxic Skin Eruption |
3.5% |
| Renal Impairment |
3.2% |
| Hyponatraemia |
3.0% |
| Overdose |
3.0% |
| Rectal Haemorrhage |
3.0% |
| Neutropenia |
2.8% |
| Subdural Haematoma |
2.8% |
| Hypoglycaemia |
2.6% |
| Malaise |
2.4% |
| Pruritus |
2.4% |
| Hepatitis Fulminant |
2.2% |
| Respiratory Distress |
2.2% |
|
| Interacting |
| Cardiomyopathy |
18.4% |
| Drug Use For Unknown Indication |
17.1% |
| Product Used For Unknown Indication |
17.1% |
| Ill-defined Disorder |
10.5% |
| Diabetes Mellitus |
9.2% |
| Cardiac Disorder |
5.3% |
| Atrial Fibrillation |
3.9% |
| Cardiac Failure |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Infection Prophylaxis |
2.6% |
| Pain |
2.6% |
| Back Pain |
1.3% |
| Bacterial Sepsis |
1.3% |
| Duodenal Ulcer |
1.3% |
| Dyslipidaemia |
1.3% |
| Hypertension |
1.3% |
| Prophylaxis |
1.3% |
|
| Torsade De Pointes |
20.8% |
| Syncope |
16.7% |
| Overdose |
12.5% |
| Renal Failure |
12.5% |
| Myoclonic Epilepsy |
8.3% |
| Bronchospasm |
4.2% |
| Drug Interaction |
4.2% |
| Haemarthrosis |
4.2% |
| Miosis |
4.2% |
| Sinus Bradycardia |
4.2% |
| Urinary Tract Infection |
4.2% |
| Vertigo |
4.2% |
|
